Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma.
Li XuYingcong WangGuanli WangShushan GuoDandan YuQilin FengKe HuGege ChenBo LiZhijian XuXinyan JiaYumeng LuHui ZhangXuejie GaoShuaikang ChangHuaping WangXiaosong WuDongliang SongGuang YangHuabin ZhuJinfeng ZhouFenghuang ZhanJianming ZhuJumei ShiPublished in: Leukemia (2023)